Professor Andrew Wei
Professor Andrew Wei is an internationally recognised leader in the field of acute myeloid leukaemia (AML). He has led nationwide trial development in Australia for 14 years as the AML chair for the ALLG. His laboratory has made pre-clinical contributions to the clinical development of BH3-mimetics in AML culminating in the regulatory approval of venetoclax […]
Professor Shyamali Dharmage
Professor Shyamali Dharmage is a world-recognised leader in epidemiology of chronic lung diseases whose research has led to paradigm changes, generated a new field of research (‘pre-COPD’) and changed guidelines worldwide. Her recognition of excellence is evidenced by national/international advisory board invitations (e.g. Lancet Commissioner in COPD), invited presentations (>90) and multiple prestigious awards (e.g. […]
Professor Susan Walker
Professor Susan Walker is a Maternal Fetal Medicine specialist and clinical academic. She is Head of the Department of Obstetrics and Gynaecology, and co-Director of Mercy Perinatal. Her research focuses on improving the detection of fetal growth restriction-the single biggest risk factor for stillbirth. She also co-leads international clinical trials of medications to prevent and […]
Professor Ego Seeman
Professor Ego Seeman is recognised as a global leader in the field of bone health through a series of studies that have transformed our understanding of the pathogenesis and treatment of osteoporosis. His pioneering studies on bone growth in utero, and delineation of sex and racial differences in bone architecture during growth help explain the […]
Professor Michael Hofman
Nuclear medicine physician‐scientist Professor Michael Hofman has pioneered use of novel radioactive molecules that seek out cancer cells for both whole body imaging and also targeted treatment. These new practice changing technologies have been adopted globally including PSMA PET imaging and radioligand therapy, demonstrating greater accuracy than standard imaging, and better outcomes and quality‐of‐life compared […]
Professor Catriona Bradshaw
Professor Catriona Bradshaw is a clinician researcher whose research has led to paradigm shifts in the diagnosis, treatment and control of drug-resistant and refractory sexually transmitted infections. She described the emergence of antibiotic-resistance in Mycoplasma genitalium, and identified new drugs and resistance-guided strategies to improve cure and antibiotic stewardship, which has repeatedly changed guidelines in […]